{
  "ticker": "RMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976213",
  "id": "02976213",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250804",
  "time": "0817",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250804/pdf/06mh0njw2rmmpn.pdf",
  "summary": "- **Form 144 Filing Summary**:  \n  - **Issuer**: ResMed Inc (NYSE: RMD)  \n  - **Executive Sale**: Brett Sandercock (Officer) proposing to sell **3,000 shares** of common stock (~$845,700 market value).  \n  - **Sale Timing**: Planned for **August 1, 2025** (per Rule 10b5-1 plan adopted February 19, 2025).  \n  - **Recent Sales**: Sold **6,527 shares** in the past 3 months (May\u2013July 2025) for total gross proceeds of **~$2.13M**.  \n  - **Securities Source**: Mix of vested restricted stock (acquired 2022\u20132024) and options exercised (granted 2018).  \n\n**Material Implications**:  \n- Liquidity impact minimal (<0.02% of outstanding shares).  \n- Routine executive disposition under prearranged plan; no adverse disclosures noted.  \n\n*Omitted: Broker details, legal boilerplate.*",
  "usage": {
    "prompt_tokens": 1660,
    "completion_tokens": 219,
    "total_tokens": 1879,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-03T22:26:56.362190"
}